The GRADE system: A change in the way of assessing the quality of evidence and the strength of recommendations;El sistema GRADE: Un cambio en la forma de evaluar la calidad de la evidencia y la fuerza de recomendaciones

Revista Medica de Chile

Volumn 142, Issue 5, 2014, Pages 630-635

  Neumann, Ignacio ^a,d,e,f   Pantoja, Tomás ^b   Peñaloza, Blanca ^b   Cifuentes, Lorena ^c   Rada, Gabriel ^a,e,f  

^a Departamento de Medicina Interna   (Chile)

^b Departamento de Medicina Clínica   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d MCMASTER UNIVERSITY   (Canada)

^e GRADE Working Group   (Chile)

^f Chile   (Chile)

Author keywords

Decision making; Evidence based practice; Practice guidelines as topic; Review

Indexed keywords

EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; PRACTICE GUIDELINE; STANDARDS;

EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE;

EID: 84906826708     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872014000500012     Document Type: Article

References (12)

1. Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, et al; GRADE Working Group. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res. 2004; 4 (1): 38.
2. Ministerio de Salud de Chile. Guía para el Diagnóstico y Manejo Clínico de casos de Infuenza (2013). Disponible en www.minsal.cl (accedido el 15 de mayo del 2014).
3. Neumann I, Cifuentes L. [Toward trustworthy clinical practice guidelines: The Ministry of Health guideline for management of Infuenza]. Rev Med Chile 2012; 140 (12): 1615-1616.
4. Secretaría Técnica AUGE. Desarrollo de guías de prác-tica clínica: manual metodológico. Ministerio de Salud, Chile; 2013.
5. Claro JC, Lustig N, Soto M, Rada G. [First step: the clinical question]. Rev Med Chile 2012; 140 (8): 1067-1072.
6. Letelier LM, Manríquez JJ, Rada G. [Systematic reviews and metaanalysis: Are the best evidence?] Rev Med Chile 2005; 133 (2): 246-249.
7. de Cates AN, Farr MR, Wright N, Jarvis MC, Rees K, Ebrahim S, Huffman MD. Fixed-dose combination therapy for the prevention of cardiovascular disease. Cochrane Database Syst Rev 2014; 4: CD009868.
8. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Ca-nonica GW, Casale TB, et al; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126 (3): 466-476.
9. Qaseem A, Snow V, Cross JT Jr, Forciea MA, Hopkins R Jr, Shekelle P, et al; American College of Physicians/ American Academy of Family Physicians Panel on Dementia. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2008; 148 (5): 370-378.
10. Alexander PE, Bero L, Montori VM, Brito J P, Stoltzfus R, Djulbegovic B, et al. World Health Organization recommendations are often strong based on low confidence in effect estimates. J Clin Epidemiol 2014; 67 (6): 629-634
11. DECIDE Consortium. Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE): protocol and preliminary results. Implement Sci 2013; 8: 6.
12. Spencer FA, Guyatt GH. Aspirin in the primary prevention of cardiovascular disease and cancer. In: UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2013.